Fraud and ethics charges hit stroke drug trial.
Enserink
M
M
D001241:Aspirin / Q000627:therapeutic use*; D001927:Brain Diseases; D002561:Cerebrovascular Disorders / Q000517:prevention & control*; D018849:Controlled Clinical Trials as Topic / Q000592:standards*; D004176:Dipyridamole / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D028744:Ethics Committees, Research; D004992:Ethics, Medical; D005060:Europe; D006801:Humans; D015337:Multicenter Studies as Topic; D010919:Placebos; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012008:Recurrence; D015871:Scientific Misconduct
D010919:Placebos; D010975:Platelet Aggregation Inhibitors; D004176:Dipyridamole; D001241:Aspirin